SP

Sanjeev Purviya

Active Director Director DIN 09236612
DIN 09236612 First appointment Jul 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value •••• Premium profile

About Sanjeev Purviya

Data last updated:

Sanjeev Purviya is a Director at Neomatis Pharma Private Limited (since 2021). The company operates in Chemicals. Neomatis Pharma Private Limited reported revenue of ₹98.9 Lakh (FY 2025).

DIN 09236612
Primary Designation Director
Industry Chemicals
First Appointment 12 Jul 2021
Oldest Company Age 5 yrs
Largest company Neomatis Pharma Private Limited · ₹98.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Neomatis Pharma Private Limited U24100MP2021PTC056653
Director12 Jul 20212021₹98.9 Lakh (FY 2025)Active

Board colleagues of Sanjeev Purviya

Directorship timeline

Open interactive timeline →
Neomatis Pharma Private Limited
Premium access

Shareholding and investment profile for Sanjeev Purviya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjeev Purviya

Sanjeev Purviya currently holds 1 directorship: Neomatis Pharma Private Limited (Director, since 12 Jul 2021, revenue ₹98.9 Lakh (FY 2025)).

Sanjeev Purviya was first appointed on 12 Jul 2021 as Director at Neomatis Pharma Private Limited.

The current boards of Sanjeev Purviya's companies include Rakesh Raghuwanshi (Neomatis Pharma Private Limited), Ramakant Yaduvanshi (Neomatis Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available